Cancer of the kidneys, also known as renal cancer, can be cured if detected early. However, symptoms may not occur until the tumor has become large or metastasized (spread to other organs), when it is difficult to treat. The majority of kidney cancers are renal cell carcinomas, also known as renal adenocarcinomas or clear cell carcinomas. Most kidney cancers affect adults between 50 and 70 years of age. The most common type of kidney cancer in children is called Wilms tumor. The July 7, 2004, issue of JAMA includes an article about renal cancer.
Grahic Jump Location
Kidney cancers most commonly occur in adults older than 50 years.
Men are twice as likely to have renal cancers as women are.
Cigarette smoking increases the risk of developing renal cell cancer.
Environmental and occupational exposures to asbestos, cadmium, and organic solvents increase the risk of developing kidney cancer.
Obesity and eating a high-fat diet have been linked with as many as 20% of kidney cancers.
von Hippel-Lindau disease is a genetic condition that has a high incidence of kidney cancer.
Hematuria (blood in the urine)
Abdominal or low back pain unrelated to injury
Unintentional weight loss
Fatigue
Anemia (low red blood cell count)
Fever
High blood pressure
Leg or ankle swelling
Diagnosis of renal cancer may involve several kinds of tests. In addition to a detailed medical history, physical examination, and laboratory blood testing, tests may include a computed tomography (CT) scan, ultrasound, magnetic resonance imaging (MRI), or intravenous pyelography (a dye and x-ray test of the kidneys). Chest x-ray and bone scan may be used to detect metastatic disease. Arteriography, a technique that uses dye in the blood vessels feeding the kidney, may define the extent of the tumor or help plan surgical treatment.
Surgical removal of the kidney (nephrectomy) and surrounding tissue may cure kidney cancer in persons whose tumor is confined to the kidney. Radiation therapy (high-energy x-ray treatments) may be offered to patients to treat pain and advanced or metastatic kidney cancers or to help shrink a tumor that is causing obstruction. Immunotherapy helps to boost the body's own immune system to fight the cancer. Interferon and interleukin 2 boost the immune system and may be used to treat patients with advanced kidney cancer. Patients who volunteer for clinical trials (medical research studies) may be offered immunotherapy in combination with experimental treatments.
American Cancer Society 800/227-2345 http://www.cancer.org
National Cancer Institute 800/4-CANCERhttp://www.cancer.gov
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on preventing cancer was published in the May 26, 2004, issue; and one on cancer clinical trials was published in the June 9, 2004, issue.
Sources: American Cancer Society, National Cancer Institute
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.
TOPIC: CANCER
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.